Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

122 ta ish

Ish: Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

  1. A guide to germ‐free and gnotobiotic mouse technology to study health and disease

    Maude Jans, Lars Vereecke

    Sharh maqola20242 iqtibos
    ABI

  2. Research advances on short-chain fatty acids in gastrointestinal acute graft- <i>versus</i> -host disease

    Xinping Song, Jing Lao, Lulu Wang +1

    Maqola20242 iqtibos
    ABI

  3. Gut microbiome alterations at acute myeloid leukemia diagnosis are associated with muscle weakness and anorexia

    Sarah A. Pötgens, Violaine Havelange, Sophie Lecop +12

    Maqola20242 iqtibos
    ABI

  4. The Impact of Gut Microbiota Changes on Methotrexate-Induced Neurotoxicity in Developing Young Rats

    Yu‐Chieh Chen, Chih‐Yao Hou, Mei‐Hsin Hsu +3

    Maqola20242 iqtibos
    ABI

  5. CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations

    Fabiana Perna, Samir Parekh, Caroline Diorio +5

    Sharh maqola20242 iqtibos
    ABI

  6. Multi-omics signatures reveal genomic and functional heterogeneity of Cutibacterium acnes in normal and diseased skin

    Tianze Yu, Xiaoqiang Xu, Yang Liu +10

    Maqola20242 iqtibos
    ABI

  7. Shotgun metagenomic insights into secondary metabolite biosynthetic gene clusters reveal taxonomic and functional profiles of microbiomes in natural farmland soil

    Bezayit Amare Kifle, Amsale Melkamu Sime, Mesfin Tafesse Gemeda +1

    Maqola20242 iqtibos
    ABI

  8. Integrating host and microbiome biology using holo-omics

    Carl M. Kobel, Jenny Merkesvik, Idun Burgos +5

    Sharh maqola20242 iqtibos
    ABI

  9. A practical introduction to holo-omics

    Iñaki Odriozola, Jacob Agerbo Rasmussen, M. Thomas P. Gilbert +2

    Sharh maqola20242 iqtibos
    ABI

  10. Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study

    Beatrice Casadei, Gabriele Conti, Monica Barone +6

    Maqola20242 iqtibos
    ABI

  11. Causal role of the gut microbiome in certain human diseases: a narrative review

    Connor Prosty, Khaled Katergi, Jesse Papenburg +8

    Sharh maqola20242 iqtibos
    ABI

  12. Metabolomics for hematologic malignancies: Advances and perspective

    Xinglan Li, Mengyu Xu, Yanying Chen +5

    Sharh maqola20242 iqtibos
    ABI

  13. A German’s Perspective on the Way toward Ambulatory Laparoscopic Cholecystectomy: A Postoperative Questionnaire

    Paul J. Weber, Konstantin Schürheck, Kim C. Wagner +3

    Maqola20242 iqtibos
    ABI

  14. Integration of metabolomics and other omics: from microbes to microbiome

    D.E. Go, Gun-Hwi Yeon, Soo‐Jin Park +7

    Sharh maqola20242 iqtibos
    ABI

  15. Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome

    Sarah Andersen, Glen Kennedy, Merrilyn Banks +2

    Maqola20252 iqtibos
    ABI

  16. Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement

    Abdelrahman Saqr, Cheng Shen, Mahmoud Al‐Kofahi +2

    Maqola20252 iqtibos
    ABI

  17. Microbiota-derived metabolites: Key modulators of cancer immunotherapies

    Markus Perl, Matthias Fante, Konstantin Herfeld +3

    Sharh maqola20252 iqtibos
    ABI

  18. Microbiota Transplantation Among Patients Receiving Long-Term Care

    Michael H. Woodworth, Ahmed Babiker, Radhika Prakash-Asrani +20

    Maqola20252 iqtibos
    ABI

  19. Microbiome-derived reactivation of mycophenolate explains variations in enterohepatic recirculation in kidney transplant recipients

    Ole Martin Drevland, Eric J. de Muinck, Pål Trosvik +5

    Maqola20252 iqtibos
    ABI

  20. The microbiome in graft-versus-host disease: a tale of two ecosystems

    Hamed Soleimani Samarkhazan, Sina Nouri, Mohsen Maleknia +1

    Sharh maqola20252 iqtibos
    ABI

  21. CF-DTI: coarse-to-fine feature extraction for enhanced drug-target interaction prediction

    Yining Qian, Qingjie Wang, Libang Yin +1

    Maqola20252 iqtibos
    ABI

  22. Metatranscriptomics-based metabolic modeling of patient-specific urinary microbiome during infection

    Jonathan Josephs‐Spaulding, Hannah Clara Rettig, Johannes Zimmermann +6

    Maqola20252 iqtibos
    ABI

  23. Microbial metabolites and their influence on the tumor microenvironment

    Huanglin Duan, Baisheng Xu, Peiyue Luo +2

    Sharh maqola20252 iqtibos
    ABI

  24. Analyzing the impact of threshold strategies on cancer treatment using non-smooth models

    Xingxiao Wu, Wenjie Qin, Sanyi Tang

    Maqola20252 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI